Skip to searchSkip to main content
Uniprism Market Research

HEALTHCARE

Global Digital PCR Market - Industry Trends and Forecast to 2032

Request Free Sample

​REPORT OVERVIEW

Global Digital PCR Market, By Product Type (Digital PCR Instruments, Consumables and Reagents, Software and Services), Product (Instruments, Reagents & Consumables), Technology (Droplet Digital PCR (ddPCR), Chip-Based Digital PCR, Other Technologies), Indication (Infectious Diseases, Oncology, Genetic Disorders, Others), Application (Clinical, Life Science and Research, Others), End-user (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Organizations, Reference Laboratories, Others), Distribution Channel (Direct Tenders, Retail Sales, Others), Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2032.

Market Insights
The global digital PCR market size is valued to be USD xx million in 2023 and is expected to reach USD xx million by 2032, and it is expected to register a CAGR of xx% over the forecast period 2024-2032.

Digital PCR (dPCR) is a precise molecular biology technology for quantifying and genotyping nucleic acids. In contrast to conventional PCR, dPCR divides a sample into thousands of separate reactions, each of which amplifies a PCR product separately. After amplification, the fluorescence signal of each partition is evaluated, allowing for highly accurate and sensitive absolute quantification of target DNA or RNA molecules. The digital PCR market includes the selling of instruments, reagents, and services linked to digital PCR technology. The capacity to precisely measure gene expression, identify uncommon mutations and evaluate viral load makes it a valuable tool for forensics, research, and diagnostics. These are some of the major uses for the technology. Major companies are investing in technological developments to improve the throughput, sensitivity, and affordability of dPCR platforms, as the market is growing due to growing demand in the environmental testing, infectious disease, and oncology sectors.

The respective global report analyses market trends, consumer behaviour and industry dynamics to guide towards entry into new markets with ease. Also, it assists in tailoring market specific and related products and services to meet the needs, preferences, and expectations of target audience by delving into their psychology. The report also specializes with comprehensive and extensive competitive analysis which offers useful insights into competitor strengths, weaknesses, opportunities, and threats. The respective report offers exclusive insights into the potential impact of disruptive developments and technologies that are expected to completely transform corporate operations. The context includes tailor-made research solutions to create a stronger footprint in their particular industries thereby offering dedicated customized solutions according to the client needs which helps in addressing unique business challenges with more simplified and efficient decision-making solutions.
Market Dynamics
DRIVERS
  • High accuracy and sensitivity in nucleic acid quantification.
  • Rising demand for early detection of diseases.
RESTRAINTS
  • High costs associated with dPCR instruments and reagents.
  • Limited awareness and infrastructure in developing regions.
OPPORTUNITIES
  • Expansion in oncology and infectious disease testing.
  • Technological advancements enhancing throughput and efficiency.
CHALLENGES
  • Standardization and regulatory challenges.
  • Competition from other quantitative PCR techniques.

​SEGMENTATION

  • Product Type
    • Digital PCR Instruments
    • Consumables and Reagents
    • Software and Services
  • Product
    • Instruments
    • Reagents & Consumables
  • Technology
    • Droplet Digital PCR (ddPCR)
    • Chip-Based Digital PCR
    • Other Technologies
  • Indication
    • Infectious Diseases
    • Oncology
    • Genetic Disorders
    • Others
  • Application
    • Clinical
    • Life Science and Research
    • Others
  • End-user
    • Pharmaceutical and Biotechnology Companies
    • Hospitals and Clinics
    • Diagnostic Laboratories
    • Academic and Research Organizations
    • Reference Laboratories
    • Others
  • Distribution Channel
    • Direct Tenders
    • Retail Sales
    • Others
The respective global report is completely customizable specific to regions (North America, Europe, Asia-Pacific, South America, Middle East and Africa), countries, and segments as per the client requirements.
REGIONAL SEGMENTATION
  • North America
    • U.S.
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • The Netherlands
    • Belgium
    • Turkey
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Singapore
    • Malaysia
    • Australia
    • Thailand
    • Philippines
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • Kingdom of Saudi Arabia
    • South Africa
    • U.A.E.
    • Egypt
    • Rest of Middle East and Africa

​KEY MARKET PLAYERS

  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • QIAGEN
  • Eppendorf SE
  • Sysmex Inostics Inc.
  • Stilla
  • RainSure Scientific
  • Accumax

​Table OF CONTENTS

  • SECTION 1 - INTRODUCTION
  • 1.1 Taxonomy
  • 1.2 Market Overview
  • 1.3 Currency and Limitations
  •   1.3.1 Currency
  •   1.3.2 Limitations
  • 1.4 Key Competitors

  • SECTION 2 - RESEARCH METHODOLOGY
  • 2.1 Research Approach
  • 2.2 Data Collection and Validation
  •   2.2.1 Secondary Research
  •   2.2.2 Primary Research
  • 2.3 Market Assessment
  •   2.3.1 Market Size Estimation
  •   2.3.2 Bottom-up Approach
  •   2.3.3 Top-down Approach
  •   2.3.4 Growth Forecast
  • 2.4 Market Study Assumptions
  • 2.5 Data Sources

  • SECTION 3 - EXECUTIVE SUMMARY
  • 3.1 Global Digital PCR Market, by Product Type
  • 3.2 Global Digital PCR Market, by Product
  • 3.3 Global Digital PCR Market, by Technology
  • 3.4 Global Digital PCR Market, by Indication
  • 3.5 Global Digital PCR Market, by Application
  • 3.6 Global Digital PCR Market, by End-user
  • 3.7 Global Digital PCR Market, by Distribution Channel
  • 3.8 Global Digital PCR Market, by Geography
  • 3.9 Market Position Grid

  • SECTION 4 - PREMIUM INSIGHTS
  • 4.1 Regulatory Framework
  •   4.1.1 Standards
  •   4.1.2 Regulatory Landscape
  • 4.2 Value Chain Analysis
  • 4.3 Supply Chain Analysis
  • 4.4 COVID-19 Impact
  • 4.5 Russia-Ukraine War Impact
  • 4.6 PORTER's Five Force Analysis
  • 4.7 PESTLE Analysis
  • 4.8 SWOT Analysis
  • 4.9 Go to Market Strategy
  • 4.10 Opportunity Orbit
  • 4.11 Multivariate Modelling
  • 4.12 Pricing Analysis

  • SECTION 5 - MARKET DYNAMICS
  • 5.1 Trends
  •   5.1.1 Increasing adoption in research and clinical diagnostics.
  •   5.1.2 Growth in personalized medicine and genomics research.
  •   5.1.3 Trend 3
  • 5.2 Drivers
  •   5.2.1 High accuracy and sensitivity in nucleic acid quantification.
  •   5.2.2 Rising demand for early detection of diseases.
  •   5.2.3 Driver 3
  •   5.2.4 Driver 4
  • 5.3 Restraints
  •   5.3.1 High costs associated with dPCR instruments and reagents.
  •   5.3.2 Limited awareness and infrastructure in developing regions.
  •   5.3.3 Restraint 3
  • 5.4 Opportunities
  •   5.4.1 Expansion in oncology and infectious disease testing.
  •   5.4.2 Technological advancements enhancing throughput and efficiency.
  •   5.4.3 Opportunity 3
  •   5.4.4 Opportunity 4
  • 5.5 Challenges
  •   5.5.1 Standardization and regulatory challenges.
  •   5.5.2 Competition from other quantitative PCR techniques.
  •   5.5.3 Challenge 3

  • SECTION 6 - GLOBAL DIGITAL PCR MARKET, BY PRODUCT TYPE
  • 6.1 Product Type Summary
  • 6.2 Market Attractive Index
  • 6.3 Global Digital PCR Market, by Product Type (2019-2032)

  • SECTION 7 - GLOBAL DIGITAL PCR MARKET, BY PRODUCT
  • 7.1 Product Summary
  • 7.2 Market Attractive Index
  • 7.3 Global Digital PCR Market, by Product (2019-2032)

  • SECTION 8 - GLOBAL DIGITAL PCR MARKET, BY TECHNOLOGY
  • 8.1 Technology Summary
  • 8.2 Market Attractive Index
  • 8.3 Global Digital PCR Market, by Technology (2019-2032)

  • SECTION 9 - GLOBAL DIGITAL PCR MARKET, BY INDICATION
  • 9.1 Indication Summary
  • 9.2 Market Attractive Index
  • 9.3 Global Digital PCR Market, by Indication (2019-2032)

  • SECTION 10 - GLOBAL DIGITAL PCR MARKET, BY APPLICATION
  • 10.1 Application Summary
  • 10.2 Market Attractive Index
  • 10.3 Global Digital PCR Market, by Application (2019-2032)

  • SECTION 11 - GLOBAL DIGITAL PCR MARKET, BY END-USER
  • 11.1 End-user Summary
  • 11.2 Market Attractive Index
  • 11.3 Global Digital PCR Market, by End-user (2019-2032)

  • SECTION 12 - GLOBAL DIGITAL PCR MARKET, BY DISTRIBUTION CHANNEL
  • 12.1 Distribution Channel Summary
  • 12.2 Market Attractive Index
  • 12.3 Global Digital PCR Market, by Distribution Channel (2019-2032)

  • SECTION 13 - GLOBAL DIGITAL PCR MARKET, BY GEOGRAPHY
  • 13.1 Regional Summary
  • 13.2 Market Attractive Index
  • 13.3 Global Digital PCR Market, by Geography (2019-2032)

  • SECTION 14 - NORTH AMERICA DIGITAL PCR MARKET
  • 14.1 North America Summary
  • 14.2 Market Attractive Index
  • 14.3 North America Digital PCR Market, by Product Type (2019-2032)
  • 14.4 North America Digital PCR Market, by Product (2019-2032)
  • 14.5 North America Digital PCR Market, by Technology (2019-2032)
  • 14.6 North America Digital PCR Market, by Indication (2019-2032)
  • 14.7 North America Digital PCR Market, by Application (2019-2032)
  • 14.8 North America Digital PCR Market, by End-user (2019-2032)
  • 14.9 North America Digital PCR Market, by Distribution Channel (2019-2032)
  • 14.10 North America Digital PCR Market, by Country (2019-2032)
  •   14.10.1 U.S.
  •   14.10.2 Canada
  •   14.10.3 Mexico
  •   14.10.4 Rest of North America

  • SECTION 15 - EUROPE DIGITAL PCR MARKET
  • 15.1 Europe Summary
  • 15.2 Market Attractive Index
  • 15.3 Europe Digital PCR Market, by Product Type (2019-2032)
  • 15.4 Europe Digital PCR Market, by Product (2019-2032)
  • 15.5 Europe Digital PCR Market, by Technology (2019-2032)
  • 15.6 Europe Digital PCR Market, by Indication (2019-2032)
  • 15.7 Europe Digital PCR Market, by Application (2019-2032)
  • 15.8 Europe Digital PCR Market, by End-user (2019-2032)
  • 15.9 Europe Digital PCR Market, by Distribution Channel (2019-2032)
  • 15.10 Europe Digital PCR Market, by Country (2019-2032)
  •   15.10.1 Germany
  •   15.10.2 U.K.
  •   15.10.3 France
  •   15.10.4 Italy
  •   15.10.5 Spain
  •   15.10.6 Russia
  •   15.10.7 The Netherlands
  •   15.10.8 Belgium
  •   15.10.9 Turkey
  •   15.10.10 Rest of Europe

  • SECTION 16 - ASIA-PACIFIC DIGITAL PCR MARKET
  • 16.1 Asia-Pacific Summary
  • 16.2 Market Attractive Index
  • 16.3 Asia-Pacific Digital PCR Market, by Product Type (2019-2032)
  • 16.4 Asia-Pacific Digital PCR Market, by Product (2019-2032)
  • 16.5 Asia-Pacific Digital PCR Market, by Technology (2019-2032)
  • 16.6 Asia-Pacific Digital PCR Market, by Indication (2019-2032)
  • 16.7 Asia-Pacific Digital PCR Market, by Application (2019-2032)
  • 16.8 Asia-Pacific Digital PCR Market, by End-user (2019-2032)
  • 16.9 Asia-Pacific Digital PCR Market, by Distribution Channel (2019-2032)
  • 16.10 Asia-Pacific Digital PCR Market, by Country (2019-2032)
  •   16.10.1 China
  •   16.10.2 India
  •   16.10.3 Japan
  •   16.10.4 South Korea
  •   16.10.5 Singapore
  •   16.10.6 Malaysia
  •   16.10.7 Australia
  •   16.10.8 Thailand
  •   16.10.9 Philippines
  •   16.10.10 Rest of Asia-Pacific

  • SECTION 17 - SOUTH AMERICA DIGITAL PCR MARKET
  • 17.1 South America Summary
  • 17.2 Market Attractive Index
  • 17.3 South America Digital PCR Market, by Product Type (2019-2032)
  • 17.4 South America Digital PCR Market, by Product (2019-2032)
  • 17.5 South America Digital PCR Market, by Technology (2019-2032)
  • 17.6 South America Digital PCR Market, by Indication (2019-2032)
  • 17.7 South America Digital PCR Market, by Application (2019-2032)
  • 17.8 South America Digital PCR Market, by End-user (2019-2032)
  • 17.9 South America Digital PCR Market, by Distribution Channel (2019-2032)
  • 17.10 South America Digital PCR Market, by Country (2019-2032)
  •   17.10.1 Brazil
  •   17.10.2 Argentina
  •   17.10.3 Chile
  •   17.10.4 Colombia
  •   17.10.5 Rest of South America

  • SECTION 18 - MIDDLE EAST AND AFRICA DIGITAL PCR MARKET
  • 18.1 Middle East and Africa Summary
  • 18.2 Market Attractive Index
  • 18.3 Middle East and Africa Digital PCR Market, by Product Type (2019-2032)
  • 18.4 Middle East and Africa Digital PCR Market, by Product (2019-2032)
  • 18.5 Middle East and Africa Digital PCR Market, by Technology (2019-2032)
  • 18.6 Middle East and Africa Digital PCR Market, by Indication (2019-2032)
  • 18.7 Middle East and Africa Digital PCR Market, by Application (2019-2032)
  • 18.8 Middle East and Africa Digital PCR Market, by End-user (2019-2032)
  • 18.9 Middle East and Africa Digital PCR Market, by Distribution Channel (2019-2032)
  • 18.10 Middle East and Africa Digital PCR Market, by Country (2019-2032)
  •   18.10.1 Kingdom of Saudi Arabia
  •   18.10.2 South Africa
  •   18.10.3 U.A.E.
  •   18.10.4 Egypt
  •   18.10.5 Rest of Middle East and Africa

  • SECTION 19 - COMPANY SHARE ANALYSIS
  • 19.1 Global Digital PCR Market, Company Share Analysis
  • 19.2 North America Digital PCR Market, Company Share Analysis
  • 19.3 Europe Digital PCR Market, Company Share Analysis
  • 19.4 Asia-Pacific Digital PCR Market, Company Share Analysis

  • SECTION 20 - COMPANY PROFILES
  • 20.1 F. Hoffmann-La Roche Ltd
  •   20.1.1 Company Snapshot
  •   20.1.2 Financial Overview
  •   20.1.3 Product Portfolio
  •   20.1.4 Recent Developments
  • 20.2 Bio-Rad Laboratories Inc.
  •   20.2.1 Company Snapshot
  •   20.2.2 Financial Overview
  •   20.2.3 Product Portfolio
  •   20.2.4 Recent Developments
  • 20.3 Merck KGaA
  •   20.3.1 Company Snapshot
  •   20.3.2 Financial Overview
  •   20.3.3 Product Portfolio
  •   20.3.4 Recent Developments
  • 20.4 Thermo Fisher Scientific Inc.
  •   20.4.1 Company Snapshot
  •   20.4.2 Financial Overview
  •   20.4.3 Product Portfolio
  •   20.4.4 Recent Developments
  • 20.5 QIAGEN
  •   20.5.1 Company Snapshot
  •   20.5.2 Financial Overview
  •   20.5.3 Product Portfolio
  •   20.5.4 Recent Developments
  • 20.6 Eppendorf SE
  •   20.6.1 Company Snapshot
  •   20.6.2 Financial Overview
  •   20.6.3 Product Portfolio
  •   20.6.4 Recent Developments
  • 20.7 Sysmex Inostics Inc.
  •   20.7.1 Company Snapshot
  •   20.7.2 Financial Overview
  •   20.7.3 Product Portfolio
  •   20.7.4 Recent Developments
  • 20.8 Stilla
  •   20.8.1 Company Snapshot
  •   20.8.2 Financial Overview
  •   20.8.3 Product Portfolio
  •   20.8.4 Recent Developments
  • 20.9 RainSure Scientific
  •   20.9.1 Company Snapshot
  •   20.9.2 Financial Overview
  •   20.9.3 Product Portfolio
  •   20.9.4 Recent Developments
  • 20.10 Accumax
  •   20.10.1 Company Snapshot
  •   20.10.2 Financial Overview
  •   20.10.3 Product Portfolio
  •   20.10.4 Recent Developments

  • SECTION 21 - RELATED REPORTS

  • SECTION 22 - DISCLAIMER

​RESEARCH METHODOLOGY

The research methodology employed in Uniprism Market Research involves four basic steps namely research and data collection, data pre-processing, modeling and forecasting, quality assurance and output.
RESEARCH AND DATA COLLECTION
A tripod model research technique is followed for research and data collection in which various approaches such as primary research, secondary research, and product mapping are considered.

Primary research basically involves the process of conducting personalized interviews with market related professionals of major market players, investors, distributors, vendors and many more.

The secondary research include data published by government, annual reports, press releases, investor presentations of companies, white papers, certified publications, annual manufacturing limit of the respective industries related to the market, production consumption analysis of certain products respective to the market and many more.

Below mention are few of the sources which we have considered while estimating the market size:
For instance,
  • Research articles published on Technium
  • Science and MDPI
  • Research publications by government approved associations and societies

Product mapping means the process of mapping the list of products that a key player contributes to the market as well as estimating the revenue of those products in order to define the Global Company share analysis of the respective Global Company in global, regional, and country level markets.
DATA PRE-PROCESSING

The term "data pre-processing" refers to the collection of procedures and methods used to clean, modify, and make ready for analysis the raw data gathered during research and data collection. The completion of this phase is necessary to guarantee that the data are reliable, consistent, and appropriate for statistical analysis and other data-driven tasks. The data pre-processing ensures that the information gathered from research and data collection is comparable and expressed in standard units, by the integration of missing data pointers and algorithmic approaches.

MODELING AND FORECASTING
The process of developing mathematical, statistical, or computational representations of real-world occurrences or relationships is known as modelling. These models are intended to replicate and explain market interactions, interdependence, and dynamics. These models are used by Uniprism Market Research to acquire a better knowledge of numerous market characteristics such as customer preferences, pricing elasticity, competition dynamics, and more. Depending on the individual study aims, many types of models are utilized, such as regression models, econometric models, decision tree models, and machine learning models.

Forecasting is the process of predicting future market conditions, trends, and occurrences using past data and models. Forecasting is used by Uniprism Market Research to estimate future sales, demand for products or services, market growth, and other important performance metrics. Forecasting accurately can assist organizations in making educated decisions about resource allocation, pricing, inventory management, and marketing tactics.

We create standardized bottom-up or top-down models that scale by leveraging data science and machine learning technology. All our market models consider the unique market characteristics of each country. Forecasting is based on major market indicators and a combination of traditional methodologies, such as exponential smoothing, time series analysis, regression analysis, and more modern techniques such as machine learning algorithms are all forecasting methodologies. The method chosen is determined on the nature of the data and the specific forecasting aims.
QUALITY ASSURANCE AND OUTPUT

Quality assurance and output involves the process of validation, adjustments, further publications of key market indicators. Extensive plausibility and consistency tests are performed on derived time series to ensure the high degree of quality of our market analysis. This quality assurance procedure also includes rigorous inspection, validation, and editing by an experienced management team to assure the dependability of the published data.

Choose License Type

  • $3599
    $4799
    $5899
    $7499